Clinical Trial to Evaluate the Food Effect on the Pharmacokinetics of Eperisone HCl SR Tablet 75mg

Phase 1CompletedNCT01885520

NVP Healthcare28 enrolled

Overview

The purpose of this study is to evaluate the food effect on the pharmacokinetics of eperisone HCl SR tablet

eperisone hydrochloride(muscle relaxant)

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Masking

NONE

Enrollment

Conditions

Low Back Pain

Interventions

fasting conditionDIETARY_SUPPLEMENT

eperisone SR tablet 75mg administrated under fasting

fed conditionDIETARY_SUPPLEMENT

eperisone SR tablet 75mg administrated fed condition

Eligibility

Sex: MALEMin age: 20 YearsMax age: 55 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Healthy male subjects age between 20 and 55 signed informed consent Exclusion Criteria: * Hypotension or hypertension has a history of allergy reaction of this drug or other drugs

Locations (1)

Kyungpook National University Hospital

Jung-gu, Daegu, South Korea

Outcomes

Primary Outcomes

AUC

Time frame: 0-24h

Cmax

Time frame: 0-24h

Secondary Outcomes

T1/2

Time frame: 0-24h

Tmax

Time frame: 0-24h

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.